Astria Therapeutics, Inc. (ATXS) Insider Trading & SEC Filings

Updated Jul 16, 2026 · Last SEC filing 2026-01-23

Astria Therapeutics, Inc. (ATXS) — no SEC Form 4 insider filings recorded in the last 90 days. InsiderAlpha tracks every ATXS SEC filing — Form 4, Form 144, and 8-K — in real time, including Rule 10b5-1 plan detection.

About Astria Therapeutics, Inc. (ATXS)

SEC CIK	0001454789

Recent ATXS Insider Transactions (Form 4)

Date	Insider	Role	Transaction	Shares	Price	Value	Filing
2026-01-23	Komjathy Andrew	Chief Commercial Officer	D — Derivative transaction	10	—	—	SEC
2026-01-23	Komjathy Andrew	Chief Commercial Officer	D — Derivative transaction	45	—	—	SEC
2026-01-23	Komjathy Andrew	Chief Commercial Officer	D — Derivative transaction	45	—	—	SEC
2026-01-23	Milne Jill C.	CEO and President	D — Derivative transaction	4.4K	—	—	SEC
2026-01-23	Violin Jonathan	Insider	D — Derivative transaction	263.3K	—	—	SEC

All transactions sourced from SEC EDGAR Form 4 filings for Astria Therapeutics, Inc. (ATXS). Updated in real time as new filings are submitted to the SEC.

Recent Insider Filings

2026-01-23 — Violin Jonathan (Insider)
2026-01-23 — Morabito Christopher (Chief Medical Officer)
2026-01-23 — Milne Jill C. (CEO and President)
2026-01-23 — Matthews Andrea (Chief Business Officer)
2026-01-23 — LAPOINTE ANTHONY GREGG (Insider)

Form 4 Transaction Code Reference

SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in ATXS insider filings:

P	Open-market purchase by the insider
S	Open-market sale by the insider
A	Grant, award, or other acquisition from the issuer
M	Exercise or conversion of derivative security (e.g. options)
F	Payment of exercise price or tax liability via share withholding
G	Bona-fide gift of securities
D	Disposition to the issuer (e.g. share buyback participation)
J	Other acquisition or disposition
X	Exercise of in-the-money or at-the-money derivative security
C	Conversion of derivative security
V	Transaction voluntarily reported earlier than required

ATXS Insider Trading — FAQ

What is the latest insider trade for ATXS?: Astria Therapeutics, Inc. (ATXS) had 0 insider filings in the last 90 days, with the most recent on 2026-01-23. InsiderAlpha tracks every Form 4, 10-K, 10-Q, and 8-K filing in real time.
How many insiders are buying ATXS stock?: 0 insider purchases of ATXS were filed in the last 90 days.
How many insiders are selling ATXS stock?: 0 insider sales of ATXS were filed in the last 90 days.
Where can I see ATXS SEC filings (Form 4, 10-K, 10-Q, 8-K)?: InsiderAlpha aggregates every ATXS SEC filing — Form 4 insider transactions, 10-K and 10-Q quarterly reports, and 8-K material event disclosures — in one timeline.

Learn More

Open the live ATXS dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.